Drug intelligence / Profile preview

PMF90

Development stage
Unknown
Lead developer
Okinawa Research Center
Modality
Small Molecules
Administration
Oral
01

Overview

PMF90 is a high-purity polymethoxylated flavonoid (PMF) extract derived from the peel of the Shikuwasa citrus fruit (*Citrus depressa*). It primarily consists of nobiletin (approximately 60-65%) and tangeretin (approximately 25-30%). Developed by the Okinawa Research Center in collaboration with Japanese academic institutions, PMF90 is utilized as a functional food and dietary supplement, particularly in Japan. Its mechanism of action involves the antagonism of muscarinic M1 receptors and the inhibition of phosphodiesterase (PDE) activity, specifically PDE5, which helps relax urinary smooth muscle and improve lower urinary tract symptoms (LUTS) such as nocturia and frequent urination. Additionally, PMF90 exhibits neuroprotective and anti-inflammatory properties by modulating the NLRP3 inflammasome and inhibiting the upregulation of connexin 43. It has been investigated for its potential to improve cognitive function in elderly subjects and attenuate neurodegeneration in preclinical models.

Brand names
NobilexNOBIREX
Other names
Nobiletin high-purity powderShikuwasa peel extractCitrus depressa peel extract
02

Targets

PDE5 (Phosphodiesterase 5A)M1 (Muscarinic acetylcholine receptor M1)

Beyond the preview

Go deeper on PMF90.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PMF90.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call